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Peripheral arterial disease (PAD) increases with age and ankle-brachial index (ABI) ≤ 0.9 is a noninvasive marker of PAD. The
purpose of this study was to identify risk factors related to a low ABI in the elderly using two diﬀerent methods of ABI calculation
(traditional and modiﬁed deﬁnition using lower instead of higher ankle pressure). A cross-sectional study was carried out with
65 hypertensive patients aged 65 years or older. PAD was present in 18% of individuals by current ABI deﬁnition and in 32%
by modiﬁed method. Diabetes, cardiovascular diseases, metabolic syndrome, higher levels of systolic blood pressure and pulse
pressure, elevated risk by Framingham Risk Score (FRS), and a higher number of total and antihypertensive drugs in use were
associated with low ABI by both deﬁnitions. Smoking and LDL-cholesterol were associated with low ABI only by the modiﬁed
deﬁnition. Low ABI by the modiﬁed deﬁnition detected 9 new cases of PAD but cardiovascular risk had not been considered high
in 3 patients when calculated by FRS. In conclusion, given that a simple modiﬁcation of ABI calculation would be able to identify
more patients at high risk, it should be considered for cardiovascular risk prediction in all elderly hypertensive outpatients.
1.Introduction
The number of elderly individuals has been progressively
increased in the last decades, and it is expected to reach 21%
of the world population by 2025 [1]. As elderly people grow,
signiﬁcant changes are observed in the mortality proﬁle for
cardiovascular diseases, and it is well known that older sub-
j e c t sh a v eb e e nu n d e r t r e a t e d[ 2]. In fact, it is very important
to identify a subset of high-risk aged patients that should
receive a more aggressive treatment. Many strategies have
been developed for this purpose, including the screening for
peripheral arterial disease (PAD). PAD increases with age
[3, 4] and can be assessed by ankle-brachial index (ABI), a
simple and noninvasive test, indicated by the ratio of ankle
to brachial systolic blood pressure. Several studies have
reportedthatABI ≤0.9isassociatedwithanincreasedriskof
death, total cardiovascular disease (CVD), coronary heart
disease (CHD), congestive heart failure, stroke, functional
decline, and dementia [5–14]. A low ABI is also predictive of
target organ damage in hypertension and should be incorpo-
rated into routine cardiovascular screening of hypertensive
patients [15–17].
There are diﬀerent formulas to calculate ABI based on
the highest or the lowest level of ankle pressure [18, 19]. The
currentguidelinesoftheAmericanHeartAssociation(AHA)
and the Inter-Society Consensus for the Management of
Peripheral Arterial Disease (TASC II) use the highest
ankle pressure as standardization [20, 21]. However, these
recommendations are not widely accepted since they could
underestimate the true prevalence of PAD [19, 22].
Thepurposeofthepresentstudywastoassessriskfactors
related to a low ABI in elderly people with hypertension,
measured by the current and modiﬁed deﬁnitions. Recog-
nizing heterogeneity and diﬀerent proﬁles among outpatient
and institutionalized old patients [10], our study focused on
those independent for activities of daily living (ADL).2 International Journal of Hypertension
Table 1: General characteristics of the study population.
Characteristic n (%)
Age (years)
65–69 19 (30%)
70–74 23 (35%)
75–80 13 (20%)
>80 10 (15%)
Male 13 (24%)
White 40 (62%)
Educational status
Illiterate 6 (9%)
Literate 59 (91%)
Falling events (>3 in the last year) 1 (1.5%)
Sensitive impairment
Visual 25 (38%)
Hearing 8 (12%)
Depressive symptoms (GDS > 5) 12 (18%)
Urinary incontinence 4 (6%)
Disturbances of motion and balance 1 (1.5%)
Polypharmacy 19 (29%)
Social support 63 (97%)
GDS: geriatric depression scale.
2. Methods
2.1. Study Population. This cross-sectional study included
patients admitted to the Outpatient Clinic of Hypertension
at State University of Rio de Janeiro in a 6-month period.
Inclusion criteria were age ≥65 years and previous diagnosis
of essential hypertension. Exclusion criteria were signiﬁcant
dependence for ADL, major cognitive deﬁcit, conditions
that precluded obtaining ABI (edema, refusing), and ABI
higher than 1.4. Eleven patients were excluded at the ﬁnal
evaluation, and a total of 65 elderly hypertensive patients
were included. The reasons for exclusion were missing visits
(n = 3), great cognitive deﬁcit by mini-mental status exam
(MMSE) (n = 2), leg edema (n = 2), ABI > 1.4 (n = 1),
normal blood pressure (BP) (n = 1), signiﬁcant dependence
(n = 1), and refusing (n = 1). The study protocol was
approved by the local ethics committee, and all patients gave
informed consent.
2.2. Clinical Evaluation. Firstly, participants included in
this study had conﬁrmed their diagnosis of hypertension.
Patients had at least two measurements of brachial BP and
were submitted to a geriatric evaluation that intended to ver-
ify cognitive status and independence for ADL. Cognitive
d e ﬁ c i tw a sd e ﬁ n e da sa nM M S Es c o r el o w e rt h a n2 3f o r
literate or lower than 18 for illiterate subjects [23, 24].
Signiﬁcant dependence for ADL was deﬁned by Katz index
of independence F and G or as a score lower than 3 [25].
Metabolic syndrome was deﬁned according to the cur-
rent Brazilian guidelines on metabolic syndrome [26], which
includes the presence of three or more of the following:
waist circumference > 102cm (men) or > 88cm (women),
BP ≥ 130/85mmHg or treatment for hypertension, triglyc-
erides ≥ 150mg/dL, HDL-cholesterol < 40mg/dL (men)
or <50mg/dL (women), and fasting plasma glucose ≥
100mg/dL. Framingham risk score (FRS) was calculated
based on the National Cholesterol Education Program.
2.3. ABI Measurements. BP cuﬀs were applied to both arms
and both ankles, and systolic BP was measured twice at
each side using 8 MHz Doppler pen probe and a pocket
ultrasonic Doppler ﬂow detector (Microem DV-10). ABI was
ﬁrst calculated according to the AHA deﬁnition by dividing
the higher systolic pressure of the right and left ankle by the
higher systolic pressure of both arms. The lowest ABI value
was selected, and the presence of PAD was deﬁned by an ABI
value of less than 0.9. The modiﬁed ABI was calculated by
considering the lower instead of the higher of the two ankle
pressures.
2.4. Biochemical Evaluation and Electrocardiogram. After 12-
hour period of fasting, venous blood was collected from
participants to measure total cholesterol, triglycerides (TG),
high-density lipoprotein cholesterol (HDL-c), glucose, crea-
tinine, and uric acid (enzymatic methods). The low-density
lipoprotein cholesterol (LDL-c) level was calculated by the
Friedewald formula when TG levels were <400mg/dL. Esti-
mated glomerular ﬁltration rate (GFR) was assessed using
Cockroft-Gault formula:
GFR =

140 − age

×weight
(creatinine × 72)

(×0.85 if female). (1)
Standard electrocardiogram (ECG) was obtained, and left
ventricular hypertrophy was diagnosed according to the
Cornell criteria whenthe sum of R-aVL and S-V3 wasat least
28mm for men or 24mm for women.
2.5. Statistical Analysis. All data are expressed as mean ±
SEM, unless otherwise stated. Unpaired Student’s t test was
usedtocomparemeans.Thechi-squaretestwasusedtoeval-
uate the association among categorical variables. Pearson’s
coeﬃcients were calculated to identify correlation between
clinical variables and ABI. All analyses were conducted in
Prism software (GraphPad version 5.0). Statistical diﬀerence
was accepted at a P value of less than 0.05.
3. Results
T h em e a na g eo fo u rs a m p l e( n = 65) was 73 years, ranging
from 65 to 90 years, and mostly composed by women (76%)
and white (62%) subjects (Table 1). A low ABI (≤0.9)
occurred in 12 (18%) subjects. There was a signiﬁcantly
higher prevalence of diabetes mellitus, cardiovascular dis-
ease, metabolic syndrome, and elevated cardiovascular risk
by FRS in the group with low ABI (Table 2). Considering all
patients in both groups, there was a moderate inverse
correlation between fasting glucose and ABI (Figure 1(a)).
Among criteria that deﬁned metabolic syndrome, the most
important factor in these older hypertensive patients was
fasting glucose (Figure 2).International Journal of Hypertension 3
Table 2: Clinical and laboratorial characteristics of the groups with normal (>0.9) and low (≤0.9) ankle-brachial index (ABI) obtained by
AHA/TASC II standardization and by modiﬁed deﬁnition.
Characteristic
AHA deﬁnition Modiﬁed deﬁnition
ABI > 0.9
(n = 53)
ABI ≤ 0.9
(n = 12) P value ABI > 0.9
(n = 44)
ABI ≤ 0.9
(n = 21) P value
Age, years 73.5 ±0.87 2 .1 ±1.3N S7 3 .4 ±0.97 2 .9 ±1.1N S
Body mass index, kg/m2 27.1 ±0.62 7 .5 ±1.6N S2 6 .7 ±0.72 8 .0 ±1.0N S
Waist circumference, cm 92.3 ±1.99 4 .7 ±3.6N S9 1 .3 ±2.09 5 .6 ±2.6N S
Metabolic syndrome, n (%) 22 (41%) 9 (75%) <0.05 17 (38%) 14 (67%) <0.05
CV diseases, n (%)† 5 (9%) 7 (58%) <0.001 3 (6%) 9 (42%) <0.001
Diabetes, n (%) 7 (13%) 10 (83%) <0.01 9 (20%) 6 (29%) <0.05
Smoker, n (%) 11 (21%) 4 (33%) NS 9 (20%) 6 (29%) <0.05
Cardiovascular risk
(i) FRS ≥ 20%, n (%) 20 (38%) 12 (100%) <0.001 16 (36%) 18 (86%) <0.001
(ii) FRS < 20%, n (%) 33 (62%) 0 (0%) <0.001 28 (63%) 3 (14%) <0.001
LV hypertrophy, n (%) 13 (24%) 5 (41%) NS 10 (23%) 8 (38%) NS
GFR, mL/min/1.73m2 68 ±36 6 ±10 NS 69 ±36 8 ±6N S
Fasting glucose, mg/dL 94 ±3.5 139 ±3.0 <0.05 98 ±2 120 ±9 <0.05
Total cholesterol, mg/dL 211 ±5 227 ±17 NS 209 ±6 223 ±10 NS
LDL-cholesterol, mg/dL 130 ±5 146 ±20 NS 124 ±5 154 ±13 <0.05
HDL-cholesterol, mg/dL 53 ±24 2 ±2 <0.05 54 ±24 3 ±20 . 0 1
Triglycerides, mg/dL 139 ±10 167 ±24 NS 141 ±11 151 ±16 NS
Uric acid, mg/dL 5.5 ±0.25 .2 ±0.4N S5 .6 ±0.25 .3 ±0.3N S
ABI, arbitrary units 1.07 ±0.01 0.81 ±0.02 <0.01 1.08 ±0.01 0.75 ±0.03 <0.001
Data are expressed as mean ± SEM or n (%) when indicated. ABI: ankle-brachial index; CV: cardiovascular; FRS: Framingham risk score; LV: left ventricular;
GFR: glomerular ﬁltration rate; LDL: low-density lipoprotein; HDL: high-density lipoprotein; NS: nonsigniﬁcant. †Include coronary heart disease: stroke, or
transitory ischemic accident.
ElderlyhypertensivepatientswithlowABIalsopresented
higher systolic BP and pulse pressure. In addition, when
the whole sample was considered for analysis, there was
an inverse correlation between pulse pressure and ABI
(Figure 1(b)). Patients in the group with low ABI were in use
of a higher number of medications, including antihyperten-
sive drugs (Table 3).
All patients enrolled in this study also had their ABI
measured by the modiﬁed deﬁnition. In this context, the
prevalence of low ABI was 32% (21 patients), which repre-
sented an additional PAD detection of 14%. The frequency
of patients presenting diabetes mellitus, cardiovascular dis-
ease, metabolic syndrome, and elevated cardiovascular risk
remained higher in the new low ABI group. Likewise, pulse
pressure, total number of medications, and antihypertensive
drugs in use were signiﬁcantly higher among these patients.
Diﬀerently when using ABI by the AHA deﬁnition, smoking
s t a t u sa n dah i g h e rl e v e lo fL D L - c h o l e s t e r o lb e c a m em o r e
prevalent in the group with a low ABI by the modiﬁed
deﬁnition (Tables 2 and 3).
4. Discussion
To the best of our knowledge, this is the ﬁrst study to com-
pare the ankle-brachial index using the higher and the lower
of the two ankle pressures on a sample focused in elderly
subjects. The present study is also the ﬁrst to evaluate PAD in
elderly persons taking into account their clinical heterogene-
ity. This was carried out by a comprehensive geriatric assess-
ment that included only subjects without great cognitive
impairment or independent for daily living activities. Thus,
this study population represents an outpatient group of
elderly literate people with a small number of falling events,
disturbances of motion and balance, urinary incontinence,
depressive symptoms, and with great social support. This
should be take into account since the clinical and geriatric
proﬁlediﬀerssigniﬁcantlyamongoutpatientsandinpatients.
In these older subjects, the prevalence (18%) of low
ABI by current deﬁnition was remarkably similar to other
studies [9, 13, 14]. Murabito et al. have found a low ABI
among 20% of their elderly cohort with a mean age of 80
years [9]. Likewise, ABI < 0.9 was associated with diabetes,
cardiovascular disease, and metabolic syndrome. In contrast
to other studies, our results demonstrated no association
between PAD and smoking status. Although it is well known
that smoking signiﬁcantly increases PAD risk in elderly
people [27, 28], we believe that this lack of association could
be related to the lower number of current smokers.
All individuals with a low ABI by the current deﬁnition
had a higher cardiovascular risk by FRS, which is additional
data to conﬁrm the relationship of ABI with cardiovascular
events. Although considering the limited accuracy of FRS,4 International Journal of Hypertension
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Figure 1: Correlation of ankle-brachial index (ABI) with fasting glucose (a) and with pulse pressure (b).
Table 3:Bloodpressurelevelsanddrugsinuseinnormalandlowankle-brachialindex(ABI)groupsdividedbyAmericanHeartAssociation
(AHA) deﬁnition and by modiﬁed deﬁnition.
Variable
AHA deﬁnition Modiﬁed deﬁnition
ABI > 0.9
(n = 53)
ABI ≤ 0.9
(n = 12) P value ABI > 0.9
(n = 44)
ABI ≤ 0.9
(n = 21) P value
Systolic BP, mmHg 152 ±3 169 ±9 <0.05 150 ±3 164 ±6 <0.05
Diastolic BP, mmHg 84 ±18 3 ±4N S8 3 ±18 5 ±3N S
Pulse pressure, mmHg 67 ±28 7 ±7 <0.01 67 78 <0.05
Total of drugs in use 3.3 ±0.36 .3 ±1.1 <0.001 3.2 ±0.35 .1 ±0.7 <0.01
(i) Acetylsalicylic acid 13 (24.5%) 8 (66.5%) <0.01 9 (20.5%) 12 (57.1%) <0.01
(ii) Statins 10 (19%) 3 (25%) NS 7 (15.9%) 5 (23.8%) NS
Antihypertensive drugs 1.9 ±0.12 .6 ±0.4 <0.05 1.9 ±0.12 .4 ±0.2 <0.05
(i) ACE inhibitors/ARB 30 (56%) 10 (83%) NS 26 (59.1%) 14 (66.6%) NS
(ii) Calcium antagonists 11 (21%) 8 (67%) <0.01 9 (20.5%) 10 (47.6%) <0.05
(iii) Beta-blockers 12 (23%) 5 (41%) NS 9 (20.5%) 8 (38.1%) NS
(iv) Diuretics 25 (48%) 5 (41%) NS 21 (47.7%) 9 (42.9%) NS
Data are expressed as mean ± SEM or n (%) when appropriate. BP: blood pressure; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blockers;
NS: nonsigniﬁcant.
since it can overestimate risk in low-risk populations and
underestimate risk in high-risk individuals, the question-
naire is still the reference standard for assessing cardiovas-
cular risk worldwide [29].
HigherlevelofsystolicBPandwideningofpulsepressure
werealsoshowedtobemoreprevalentamongthosewithABI
≤ 0.9. These were expected results since there is increasing
systolic and falling diastolic BP related to ageing [30, 31].
These ﬁndings also conﬁrm other studies that reported the
association between pulse pressure and PAD [32, 33]. On
the other hand, no diﬀerence was observed regarding systolic
hypertension diagnosis, which may reﬂect a stronger associ-
ation with the magnitude of BP level. The lack of association
of ABI and left ventricular hypertrophy probably is more
associated with the limited accuracy of electrocardiography
than with the real pathological myocardial injury.
The current study also observed the relationship between
low ABI and the number of drugs in use, considering both all
drugs and only the antihypertensive medications. These data
suggest that ABI ≤ 0.9 could be associated with a great num-
ber of morbidities and a diﬃculty to treat hypertension. Fur-
thermore, acetylsalicylic acid and calcium channel antago-
nists were more widespreadly prescribed to our patients with
low ABI, which may reﬂect a greater prevalence of cardiovas-
cular diseases and more resistant hypertension in this group.
No diﬀerence was found in relation to glomerular ﬁltra-
tion rate. This result contrasts with other papers where low
ABI was associated with an impairment in kidney functionInternational Journal of Hypertension 5
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Figure 2: Proportion of criteria for metabolic syndrome in the
study population.
andhigherlevelsofcreatinine[34,35].Evaluatingoutpatient
subjects,O’Hareetal.havefoundthatABIlowerthan0.9was
more prevalent than ABI of 1.0 or higher in patients with a
50% increase in serum creatinine during a 3-year follow-up.
A lack of association was also observed between uric acid
and ABI. Although most data currently point out a rela-
tionship between increased uric acid and low ABI [36, 37],
no study exclusively evaluated elderly people. No diﬀerence
was noted about total cholesterol levels, which is similar to
other studies [5, 38, 39]. Indeed, it is not known whether
cholesterol is really associated with PAD. On the other hand,
reduced HDL-cholesterol levels were more frequent among
hypertensive elderly subjects with low ABI, which probably
reﬂectsthehigherprevalenceofmetabolicsyndromeinthese
patients.
Low ABI by the modiﬁed deﬁnition detected nine addi-
tional patients with PAD. This was an expected ﬁnding
since the method sensitivity was changed. These data were
also similar to those reported by Espinola-Klein et al. who
indicated 10.8% greater detection of newer subjects with
PAD by the modiﬁed ABI [40]. Low ABI by the modiﬁed
deﬁnition was also associated with a greater prevalence of
diabetes, cardiovascular diseases, and metabolic syndrome;
elevated risk by Framingham score; higher levels of systolic
BP, pulse pressure, and number of total and antihypertensive
drugs in use. These ﬁndings suggest that modiﬁed deﬁnition
at least has the same value of current deﬁnition.
Besides detecting more patients with PAD, the most
important diﬀerence obtained from the modiﬁed ABI def-
inition was the association with smoking status and LDL-
cholesterol. By detecting a relationship between smokers and
PAD, this could be the ﬁrst result to suggest a greater value
to the modiﬁed deﬁnition. The same interpretation could be
appliedtoLDL-cholesterol,althoughthisassociationismuch
more questionable than with smoking.
Concerning cardiovascular risk, it should be noticed that
3 of the 21 subjects with low ABI had not high risk by FRS.
These patients did not have diabetes, a positive smoking sta-
tus,oranycardiovasculardisease.Otherwise,theywereobese
and had metabolic syndrome and one presented left ventric-
ular hypertrophy by electrocardiogram. Although additional
evaluationisnecessaryinthesepatientstoassessthepresence
of atherosclerosis, these ﬁndings suggest that ABI measure-
ment, especially by a modiﬁed deﬁnition, could improve the
accuracy of cardiovascular risk prediction beyond FRS in the
elderly. Recently, a meta-analysis, including persons with age
between 47 and 78 years, concluded that ABI measurement
could improve the accuracy of cardiovascular risk prediction
beyondFRS.InclusionoftheABIincardiovascularriskstrat-
iﬁcation using the FRS resulted in reclassiﬁcation of the risk
category and modiﬁcation of treatment recommendations in
approximately 19% of men and 36% of women [36].
Some limitations of the present study should be consid-
ered. Firstly, this sample cannot be extrapolated to patients
older than 80 years or living in nursing homes and other
institutions. Secondly, when electing just subjects inde-
pendent for daily living activities and without signiﬁcant
cognitive impairment, a survival bias is obtained since more
fragile patients were excluded from analysis. Furthermore,
we have common limitations with cross-sectional studies
when compared to cohort studies, mainly the diﬃculty in
establishing cardiovascular risk. These issues will be reduced
as additional data from the original cohort are obtained.
5. Conclusion
In conclusion, the incorporation of clinical markers of
asymptomatic atherosclerosis such as ABI can improve
prediction of healthy older individuals at high risk of car-
diovascular disease. This is the ﬁrst study to compare two
ABI deﬁnitions focusing on elderly hypertensive patients
taking into account the typical heterogeneity of this group.
Considering that a simple modiﬁcation of the index, using
the lower instead of the higher ankle pressure, would identify
more patients at risk, the use of a modiﬁed ABI calculation
should be considered for cardiovascular risk prediction in all
hypertensive outpatients older than 65 years.
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